Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Multi-billion dollar valuation set for dynaCERT Inc. (V.DYA), pieces falling into place

dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) this week announced it has received its European ABE (German for “permit of operation”) certification for the Company’s HydraGEN™ (HG) Carbon Emission Reduction Technology fo...
James O'Rourke | August 27, 2019 |

XPhyto: The Cutting Edge of Medical Cannabis Science

At the forefront of the next wave of cannabis commercialization, is a German-focused company with headquarters in Vancouver, XPhyto Therapeutics Corp. (CSE: XPHY; FSE: 4XT) , that is building a much-coveted cannabis R&D cultivation facility in a converted nuclear bunker and o...
Marc Davis | November 12, 2019 |

Will Trump’s Stimulus Hint Turn Stocks Around?

After Thursday’s rise, stocks went ever deeper into red since. Driven by incoming bad coronavirus news both in the US and abroad, not even Friday’s strong employment data stopped the selling. Monday’s bloodbath even caused tradin...
Monica Kingsley | March 10, 2020 |

Psychedelic Leader to Advance Mental Health in 2021 with Growth of Clinics, Lab and Partnerships

(Image via Numinus Wellness Inc.) In 2020, Health Canada began allowing select patients to take psilocybin for relief of end-of-life-distress. This was followed by a proposed regulation revision that could allow doctors to prescribe both psilocybin and MDMA for t...
Stockhouse Editorial | January 14, 2021 |

Kincora Releases First Copper-Gold Assays at Mongolia Project

On September 10th Kincora Copper Ltd. (KCC:TSX.V) provided the first drilling update at its 100%-owned copper-gold porphyry projects in the Southern Gobi region of Mongolia. This update comes after an oversubscribed $6.25 million equity raising in late June. First p...
Streetwise Reports | September 24, 2019 |

Mexican gold junior I really like

Editor’s note: The Pediment Gold story was first reported by Ticker Trax’s Thom Calandra in an article posted her e . I first wrote about Pediment Gold Corp ( TSX: T.PEZ , Stock Forum ) in a private report delivered on June 18, 2007....
Michael S. (Mickey) Fulp | October 28, 2012 |

PCR Testing: XPhyto Disrupts a Blockbuster Business

It’s the technological evolution that could transform the US $84.4 billion Covid-19 diagnostics market. Vancouver-based life sciences company XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) (OTC: XPHYF) expects its rapid Covid-19 test system to be approv...
Marc Davis | February 25, 2021 |

XPhyto Therapeutics: Are they Selling the Solution to Germany’s Rapid Testing Crisis?

The Germans call it COVID-19 “rapid testing mania”. But like most manias, it has opened up a Pandora’s box of problems. As the speed of the vaccine rollout program falters in Europe, on-the-spot antigen testing continues to be the ...
Marc Davis | June 2, 2021 |

XPhyto Announces a PCR Testing Breakthrough

It’s the technological breakthrough that the world has been waiting for. A small Canadian life sciences company, XPhyto Therapeutics Corp. ( CSE:XPHY ) (FSE:4XT), has just announced its ability to significantly speed up testing for COVID-19 in an...
Marc Davis | December 17, 2020 |

XPhyto: Why Rapid PCR Testing is Here to Stay

Regular coronavirus testing is destined to become the norm for many years to come, regardless of how many people get vaccinated against COVID-19. So says Hugh Rogers, the CEO of XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) ( OTC: XPHYF ) , a Canadian life scie...
Marc Davis | April 22, 2021 |
1 2 3 4 5 6 7 8 9 10 ...